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Objective: The wall shear stress generated by blood flow regulates the 
expression of fibrinolytic proteins by endothelial cells in vitro. In the 
present study, the effects of pulmonary blood flow on fibrinolytic activity 
were studied in patients with congenital heart defects and pulmonary 
hypertension. Methods: Twenty-seven patients who underwent cardiac op- 
eration because of congenital heart defects were divided into four groups 
according to the severity of pulmonary hypertension. Group I consisted of 
seven patients with normal pulmonary artery pressure, group II consisted 
of nine patients with pulmonary hypertension caused by increased pulmo- 
nary blood flow. group III consisted of six patients with pulmonary 
hypertension caused by increased pulmonary vascular resistance, and 
group IV consisted of five patients with tetralogy of Fallot. Plasma 
concentrations of tissue plasminogen activator, plasmin, and thrombin 
were assayed as the inhibitor-bound forms. Results: The preoperative 
concentration of tissue plasminogen activator was higher in group II than 
in all other groups (p = 0.0003"}. However, the postoperative concentration 
decreased only in patients in group II when compared with the preoperative 
value (p -- 0.01). By Pearson's correlation analysis, pulmonary blood flow 
was found to correlate with the preoperative concentration of tissue 
plasminogen activator (95% confidence interval = 3.99 to 10.58. p = 
0.0001). No definite conclusion was found for the relationship between 
tissue plasminogen activator and plasmin concentration. Further, the 
preoperative thrombin concentration was similar in all groups. Conclusions: 
These findings Suggest that pulmonary blood flow may regulate the plasma 
concentration of tissue plasminogen activator in patients with congenital 
heart defects. (J Thorac Cardiovasc Surg 1997:113:742-7} 
H emodynamic forces have been shown to influ- 
ence the structure and function of vascular en- 
dothelial cells. 14 Endothelial cells respond to me- 
chanical stress by altering gene expression and by 
undergoing significant structural reorganization. 5 
Specifically, the endothelial cell is the primary 
source of tissue plasminogen activator (t-PA) 6 and is 
also responsible for the production of several plas- 
minogen activator inhibitors. It has already been 
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reported that fluid shear stress increases t-PA at 
both the protein 7 and messenger ribonucleic acid 8 
levels of endothelial cells in vitro. 
Patients with congenital heart defects with left-to- 
right shunting of blood often have pulmonary hy- 
pertension as a result of increased pulmonary blood 
flow. In some patients, this results in a progressive 
increase in pulmonary vascular esistance?' 10 The 
severity of the pulmonary vascular changes deter- 
mines the patient's prognosis and the outcome of 
surgical intervention. Increased pulmonary blood 
flow is believed to increase fluid shear stress on the 
endothelial surface of the lung. Endothelial cells 
may initially respond to these hemodynamic changes 
by altering their structure and function to maintain 
adequate pulmonary circulation. Although fibrino- 
lytic activity is recognized as important in this adap- 
tation, few studies of the interaction between fi- 
brinolytic activity and hemodynamic forces in 
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Fig. 1. Preoperative plasma tPALC concentrations. The mean plasma concentration for group II was 
higher than the values for the other three groups. There was no statistical difference between groups I, III, 
and IV. Values are mean plus or minus the standard error of the mean. *p = 0.0001 versus group I; *p = 
0.0003 versus groups III and IV. 
patients with congenital heart defects have been 
reported. To investigate the role of pu lmonary  
blood flow in fibrinolytic activity in patients with 
congenital heart defects and pulmonary hyperten- 
sion, we examined plasma concentrations of t-PA, 
plasmin, and thrombin before and after cardiac 
operations. 
Patients and methods 
Twenty-seven children with congenital heart defects 
who underwent intracardiac repair between November 
1994 and May 1995 were included in the study. The ages 
at the time of operation ranged from 1 month to 3 years 
(median age, 9 months). The diagnoses included ventric- 
ular septal defect (12 patientS, with associated coarctation 
of the aorta in 2 patients), tetralogy of Fallot (5 patients), 
atrioventrieular septal defect (4 patients), and double- 
outlet right ventricle (2 patients). The remaining four 
patients had a variety of congenital defects. Twenty-two 
patients excluding those with tetralogy of Fallot were 
divided into three groups according to the severity of 
pulmonary hypertension, which was evaluated by cardiac 
catheterization e half month to 5 months before oper- 
ation. Group I consisted of seven patients with normal or 
slightly increased pulmonary arterial pressure (the ratio of 
pulmonary artery to aortic systolic pressure [PUPs] -<0.5), 
group II consisted of nine patients with pulmonary hyper- 
tension caused by increased pulmonary blood flow (Pp/Ps 
>0.5; the ratio of pulmonary to systemic blood flow 
Table I. Ratios forpressure, flow, and resistance 
Variable Group I Group H Group H
n 7 9 6 
Pressure (Pp/Ps) 0.33 + 0.1 0.94 _+ 0.07 0.92 ± 0.07 
Flow (Op/Qs) 1.64 _+ 0.34 3.35 _+ 1.08 1.31 ± 0.39 
Resistance (Rp/Rs) 0.13 _+ 0.01 0.28 _+ 0.09 0.73 _~ 0.15 
Values are mean plus or minus the standard deviation. 
volume [Qp/Qs] >2), and group iII consisted of six 
patients with pulmonary hypertension caused by elevation 
in pulmonary vascular esistance (Pp/Ps >0.5, Qp/Qs -<2). 
Group IV was a control group (tetralogy of Fallot) and 
consisted of five patients with decreased pulmonary blood 
flow. 
The ratios for pressure, flow, and resistance in groups I, 
II, and III are shown in Table I. All cardiopulmonary 
bypass (CPB) procedures were done at moderate hypo- 
thermia with crystalloid cardioplegia. The CPB times 
ranged from 82 to 339 minutes (mean plus or minus 
standard deviation, 183.9 ± 76.1 minutes), including 
circulatory assistance time with CPB. 
Arterial blood samples were obtained from all patients 
before operation and 1 hour after CPB. Venous blood 
samples were obtained 4 to 13 months after the operation 
from 14 patients, including 1 in group I, 5 in group II, 5 in 
group III, and 3 in group IV (those patients who were 
followed up at Our department). Plasma was separated by 
centrifugation at 4 ° C, immediately frozen, and stored at 
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Fig. 2. Distribution of the preoperative plasma tPAI-C concentration and pulmonary flow ratio (Qp/Qs) 
in 22 patients in groups I, II, and III. The data showed a correlation between the preoperative tPAI-C 
concentration and pulmonary blood flow: r = 0.65, 95% confidence interval = 0.32 to 0.83, p = 0.001. 
Table II. Effect of pulrnonary blood flow on the preoperative plasma tPAI-C concentration 
Variable [3 SE 95% CI p Value 
Pulmonary pressure (Pp/Ps) 1.928 i.549 - 1.263 to 5.129 0.2255 
Pulmonary flow (Qp/Qs) 7.282 1.594 3.998 to 101565 0.0001 
Pulmonary hypertension and high pulmonary blood flow were defined as Pp/Ps >0.5 and Qp/Qs >2, respectively. SE, Standard error; CI, confidence interval. 
Pearson's correlation analysis was used. p Value for the model: 0.0001, R-square: 0.623. 
-60 ° C. Informed consent for blood sampling was ob- 
tained from the parents of each child. 
Plasma concentrations of t-PA, plasmin, and thrombin 
were assayed as inhibitor-bound forms: t-PA-plasmino- 
gen activator inhibitor 1 complex (tPAI-C), plasmin-% 
plasmin inhibitor complex (PIC), and thrombin-anti- 
thrombin III complex (TAT). Plasma concentrations of 
tPAI-C and PIC were measured with the use of commer- 
cially availabIe enzyme-linked immunosorbent assay kits 
(Teijin Ltd., Japan). TM i2 Plasma concentrations of TAT 
were also determined with an enzyme-linked immunosor- 
bent assay kit (Behringwerke, Germany). ~3 
Statistical analysis was done with Statistical Analysis 
Systems oftware for the personal computer (SAS Insti- 
tute, Cary, N.C.). Values for quantitative variables were 
expressed as the mean plus or minus the standard error of 
the mean except for those in Table I. Statistical differences 
among the groups were determined by the permutation 
test. Changes in the values of variables were compared by 
the paired Student's t test. A correlation matrix was used 
to determine the relationship between two variables. To 
determine independent predictors of plasma tPAI-C con- 
centration, pulmonary artery pressure and pulmonary 
blood flow values were subjected to Pearson's correlation 
analysis. The 95% confidence interval and the actual p 
value were reported. Statistical significance was accepted 
at a level ofp < 0.05 (two-sided tests). 
Results 
The preoperat ive plasma tPAI -C concentrations 
for each group are depicted graphically in Fig. 1. 
The mean plasma tPAI -C concentration for group I I  
was greater than those of all other groups (14.8 _+ 
1.7 vs 5.6 to 6.2 _+ 0.6 to 0.9 ng/ml, p = 0.0001 to 
0.0003). The preoperat ive plasma tPAI -C concen- 
trations correlated with the pulmonary flow ratio 
(Qp/Qs) in groups I, II, and I I I  as shown in Fig. 2 
(p = 0.001). On the basis of Pearson's correlation 
analysis, pulmonary blood flow was proport ional to 
the preoperat ive plasma concentration of tPAi -C 
(p = 0.0001); however, pulmonary artery pressure 
was not proport ional  (/7 = 0,23) (Table II). One 
hour after CPB, concentrations of tPAI -C increased 
in all patients with the mean tPAI -C concentration 
increasing from 8.5 _+ 1.1 to 20.6 + 2.0 ng/ml (p = 
2.5 × 10 7). The plasma tPAI -C concentration after 
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Fig. 3. Changes in the plasma tPAI-C concentration in response to intracardiac repair. The postoperative 
plasma tPAI-C concentration was measured in 14 patients 4 to 13 months after the operation. The 
postoperative concentration for group II was lower than the preoperative concentration. Values are mean 
plus or minus the standard error of the mean. *p = 0.01, 95% confidence interval = -16.73 to -4.06 by 
Student's paired t test comparing preoperative and postoperative alues. 
CPB correlated with CPB time (r = 0.52, 95% confi- 
dence interval = 0.16 to 0.76, p = 0.008). Four to 13 
months after intracardiac repair, tPAI-C concentra- 
tions for groups I, Ill, and IV (n = 9) returned to 
preoperative l vels and those for group II (n = 5) 
decreased from preoperative l vels to 4.9 _+ 0.5 ng/ml 
as shown in Fig. 3 (p = 0.01). There were no statistical 
differences in the tPAI-C concentrations among the 
four groups after the operations (p = 0.82). 
The mean plasma PIC concentration 1 hour after 
CPB increased compared with the preoperative 
value (0.86 _+ 0.05 vs 0.50 + 0.11/xg/ml, p = 0.025 ). 
There was no statistical correlation between tPAI-C 
and PIC values either before operation (r = -0.43, 
95% confidence interval = -0.95 to 0.72,p = 0.46) 
or after CPB (r = 0.2l, 95% confidence interval = 
-0.82 to 0.92, p = 0.73); however, no definite 
conclusion was obtained from these data. Preoper- 
ative plasma concentrations of TAT were similar 
between each group (group I, 7.4 + 2.7 ngflml; group 
II, 7.9 _+ 2.7 ng/ml; group III, 6.9 + 3.9 ng/ml; and 
group IV, 4 _+ 0.5 ng/ml, p = 0.75). 
Discussion 
In patients with congenital heart defects and 
associated left-to-right shunting, the pulmonary vas- 
cular endothelial cells are subjected to mechanical 
forces out of the physiologic range. These forces 
include shear stress caused by increased pulmonary 
blood flow and mechanical strain caused by elevated 
pulmonary artery pressures. In the present study, we 
investigated fibrinolytic activity by plasma tPAI-C 
concentration i patients with congenital heart de- 
fects, who were divided into four groups according 
to pulmonary blood flow and pulmonary artery 
pressure. The presence of tPAI-C in plasma is a 
direct indicator of in vivo generation of t-PA. 11' 14 
As the results demonstrate, increases in plasma 
tPAI-C concentrations depend on pulmonary blood 
flow and not on pulmonary artery pressure. When 
pulmonary blood flow returned to normal after the 
operation, the plasma concentration of tPAI-C in 
group II decreased to a level similar to those of the 
other three groups. 
These findings demonstrate hat high shear stress, 
produced by increased pulmonary blood flow in the 
setting of congenital heart defects, results in in- 
creased secretion of tPAI-C by stimulated pulmo- 
nary vascular cells. In previous experimental studies, 
fluid shear stress was found to stimulate t-PA secre- 
tion in cultured human endothelial cells 7' 8 and to 
downregulate ndothelial expression of thrombo- 
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modulin in cultured bovine aortic endothelial 
cells, is Endothelial cells also synthesize prostacy- 
clin 16 and release nitric oxide 17 when stimulated by 
shear stress. These bioactive agents erve to inhibit 
blood coagulation. 
In 11 patients including three in group I, five in 
group II, and three in group Ill, shear stress (r, 
dynes per square centimeter) at the right pulmonary 
artery was calculated according to the following 
equationl8: 
r = 4ttQp/wr 3
where/x represents whole blood viscosity (0.03 P), 
Qp is the flow rate of the right pulmonary artery (in 
milliliters per second), and r is the internal radius of 
the right pulmonary artery (in centimeters). The 
value of shear stress was 3.6 -+ 1 dyn/cm 2in group I, 
6.1 _+ 1.2 dyn/cm 2in group II, and 3.8 _+ 1.5 dyn/cm 2
in group III. The value statistically correlated with 
the preoperative plasma tPAI-C concentration (r = 
0.69, 95% confidence interval = 0.15 to 0.91, p = 
0.02). 
Plasma concentrations of tPAI-C after CPB in- 
creased in statistical correlation with CPB time in 
the present study. However, in four patients, in 
whom plasma tPAI-C concentrations in the pulmo- 
nary artery and vein were measured simultaneously 
1 hour after CPB, there was no statistical difference 
between the values (26 + 6.1 vs 25.8 + 7.1 ng/ml, 
p = 0.91). Therefore these increases might be 
caused by the endothelial response of systemic 
arteries to CPB. 
It is well known that TAT and PIC are measures 
of thrombin and plasmin generation, respective- 
ly,19.20 and that the substrates for these complexes 
are synthesized in the liver. Therefore it seems 
reasonable that in patients with congenital heart 
defects the plasma TAT and PIC concentrations 
might not change irrespective of tPAI-C concentra- 
tions. The effect of shear stress on the production of 
coagulation factors by vascular endothelial cells has 
rarely been studied. Recently, it was reported that 
human umbilical vein endothelial cells subjected to 
fluid shear stress, when activated by interleukin-loe, 
are able to generate significant quantities of factor 
Xa. 21 
Increased secretion of t-PA is thought to be a 
reactive change that results from high shear stress 
caused by increased pulmonary blood flow. In- 
creased concentrations of t-PA may contribute to 
maintenance of pulmonary blood flow by inhibiting 
a thrombotic tendency. Once pulmonary vascular 
obstructive disease develops in patients with con- 
genital heart defects, a reduction in pulmonary 
blood flow and in secretion of t-PA may result in a 
comparable prothrombotic situation. 
Hemodynamic forces change the structure and 
function of pulmonary vascular endothelial cells. 
On the other hand, vascular changes, including 
endothelial cell changes, may affect the hemody- 
namics associated with congenital heart defects. 
In conclusion, our results suggest that shear stress 
generated by increased pulmonary blood flow may 
regulate the plasma concentrations of tPAI-C in 
patients with congenital heart defects. Increased 
concentrations of tPAI-C may be important to 
maintain pulmonary blood flow. 
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